Lifemd Inc Stock Analysis
LFMD Stock | USD 6.59 0.23 3.62% |
LifeMD Inc is fairly valued with Real Value of 6.44 and Target Price of 7.75. The main objective of LifeMD stock analysis is to determine its intrinsic value, which is an estimate of what LifeMD Inc is worth, separate from its market price. There are two main types of LifeMD's stock analysis: fundamental analysis and technical analysis.
The LifeMD stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and LifeMD's ongoing operational relationships across important fundamental and technical indicators.
LifeMD |
LifeMD Stock Analysis Notes
About 16.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.64. LifeMD Inc last dividend was issued on the 14th of October 2020. The entity had 1:5 split on the 14th of October 2020. LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, mens sexual health, dermatology, and others in the United States. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. LifeMD operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 196 people. To find out more about LifeMD Inc contact Justin Schreiber at 866 351 5907 or learn more at https://lifemd.com.LifeMD Quarterly Total Revenue |
|
LifeMD Inc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. LifeMD's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding LifeMD Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
LifeMD Inc is way too risky over 90 days horizon | |
LifeMD Inc appears to be risky and price may revert if volatility continues | |
LifeMD Inc currently holds 18.93 M in liabilities with Debt to Equity (D/E) ratio of 0.46, which is about average as compared to similar companies. LifeMD Inc has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about LifeMD's use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 152.55 M. Net Loss for the year was (20.6 M) with profit before overhead, payroll, taxes, and interest of 100.37 M. | |
LifeMD Inc has a frail financial position based on the latest SEC disclosures | |
About 16.0% of LifeMD outstanding shares are owned by corporate insiders | |
Latest headline from MacroaxisInsider: Acquisition by Nicholas Alvarez of 75000 shares of LifeMD subject to Rule 16b-3 |
LifeMD Inc Upcoming and Recent Events
27th of March 2024 Upcoming Quarterly Report | View | |
10th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
LifeMD Largest EPS Surprises
Earnings surprises can significantly impact LifeMD's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | -0.12 | -0.14 | -0.02 | 16 | ||
2024-03-11 | 2023-12-31 | -0.14 | -0.12 | 0.02 | 14 | ||
2024-05-08 | 2024-03-31 | -0.15 | -0.19 | -0.04 | 26 |
LifeMD Environmental, Social, and Governance (ESG) Scores
LifeMD's ESG score is a quantitative measure that evaluates LifeMD's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of LifeMD's operations that may have significant financial implications and affect LifeMD's stock price as well as guide investors towards more socially responsible investments.
LifeMD Thematic Classifications
In addition to having LifeMD stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
LifeMD Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Northern Trust Corp | 2024-09-30 | 317.3 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 284.8 K | Nuveen Asset Management, Llc | 2024-06-30 | 284 K | Next Century Growth Investors Llc | 2024-06-30 | 277.6 K | Quinn Opportunity Partners Llc | 2024-09-30 | 269 K | Bridgeway Capital Management, Llc | 2024-09-30 | 251.2 K | Deerfield Management Co | 2024-09-30 | 241.3 K | Bank Of New York Mellon Corp | 2024-06-30 | 234.6 K | Acadian Asset Management Llc | 2024-06-30 | 222.9 K | Blackrock Inc | 2024-06-30 | 2.3 M | Vanguard Group Inc | 2024-09-30 | 1.7 M |
LifeMD Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 275.46 M.LifeMD Profitablity
The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.47) | (0.50) | |
Return On Capital Employed | (0.61) | (0.58) | |
Return On Assets | (0.35) | (0.37) | |
Return On Equity | (5.88) | (6.17) |
Management Efficiency
LifeMD Inc has return on total asset (ROA) of (0.2134) % which means that it has lost $0.2134 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.8248) %, meaning that it created substantial loss on money invested by shareholders. LifeMD's management efficiency ratios could be used to measure how well LifeMD manages its routine affairs as well as how well it operates its assets and liabilities. As of November 30, 2024, Return On Tangible Assets is expected to decline to -0.5. The current year's Return On Capital Employed is expected to grow to -0.58. At present, LifeMD's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 44.7 M, whereas Net Tangible Assets are projected to grow to (16.7 M).Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.16 | 0.17 | |
Tangible Book Value Per Share | (0.27) | (0.26) | |
Enterprise Value Over EBITDA | (32.49) | (34.11) | |
Price Book Value Ratio | 80.18 | 84.19 | |
Enterprise Value Multiple | (32.49) | (34.11) | |
Price Fair Value | 80.18 | 84.19 | |
Enterprise Value | 266.9 M | 280.2 M |
LifeMD Inc has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Operating Margin (0.09) | Profit Margin (0.12) | Beta 1.232 | Return On Assets (0.21) | Return On Equity (7.82) |
Technical Drivers
As of the 30th of November, LifeMD secures the Downside Deviation of 4.89, risk adjusted performance of 0.0805, and Mean Deviation of 3.85. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LifeMD Inc, as well as the relationship between them. Please verify LifeMD Inc standard deviation, value at risk, kurtosis, as well as the relationship between the jensen alpha and semi variance to decide if LifeMD Inc is priced some-what accurately, providing market reflects its recent price of 6.59 per share. Given that LifeMD Inc has jensen alpha of 0.0647, we recommend you to check LifeMD's last-minute market performance to make sure the company can sustain itself at a future point.LifeMD Inc Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. LifeMD middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for LifeMD Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
LifeMD Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LifeMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on LifeMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LifeMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
LifeMD Outstanding Bonds
LifeMD issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LifeMD Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LifeMD bonds can be classified according to their maturity, which is the date when LifeMD Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
LifePoint Health 4375 Corp BondUS53219LAS88 | View | |
US53219LAU35 Corp BondUS53219LAU35 | View |
LifeMD Predictive Daily Indicators
LifeMD intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of LifeMD stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
LifeMD Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 24th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 12th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 20th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13th of August 2024 Other Reports | ViewVerify |
LifeMD Forecast Models
LifeMD's time-series forecasting models are one of many LifeMD's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary LifeMD's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About LifeMD Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how LifeMD prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling LifeMD shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as LifeMD. By using and applying LifeMD Stock analysis, traders can create a robust methodology for identifying LifeMD entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.11) | (0.12) | |
Operating Profit Margin | (0.09) | (0.10) | |
Net Loss | (0.14) | (0.14) | |
Gross Profit Margin | 0.88 | 0.61 |
Current LifeMD Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. LifeMD analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. LifeMD analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
7.75 | Strong Buy | 7 | Odds |
Most LifeMD analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand LifeMD stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of LifeMD Inc, talking to its executives and customers, or listening to LifeMD conference calls.
LifeMD Stock Analysis Indicators
LifeMD Inc stock analysis indicators help investors evaluate how LifeMD stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading LifeMD shares will generate the highest return on investment. By understating and applying LifeMD stock analysis, traders can identify LifeMD position entry and exit signals to maximize returns.
Begin Period Cash Flow | 4 M | |
Long Term Debt | 17.9 M | |
Common Stock Shares Outstanding | 33.9 M | |
Total Stockholder Equity | 3.5 M | |
Tax Provision | 428 K | |
Property Plant And Equipment Net | 1.1 M | |
Cash And Short Term Investments | 33.1 M | |
Cash | 33.1 M | |
Accounts Payable | 11.1 M | |
Net Debt | -14.2 M | |
50 Day M A | 5.1014 | |
Total Current Liabilities | 34.8 M | |
Other Operating Expenses | 167 M | |
Non Current Assets Total | 15.9 M | |
Forward Price Earnings | 27.6243 | |
Non Currrent Assets Other | -1.00 | |
Stock Based Compensation | 12.5 M |
Complementary Tools for LifeMD Stock analysis
When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Transaction History View history of all your transactions and understand their impact on performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |